Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pivotal Study of the Safety and Effectiveness of Autologous Bone Marrow Aspirate Concentrate (BMAC) for the Treatment of Critical Limb Ischemia Due to Peripheral Arterial Disease

NCT01245335 is registered in ClinicalTrials.gov with Harvest Technologies as lead sponsor.

NCT NCT01245335
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01245335 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pivotal Study of the Safety and Effectiveness of Autologous Bone Marrow Aspirate Concentrate (BMAC) for the Treatment of Critical Limb Ischemia Due to Peripheral Arterial Disease
Lead sponsor
Harvest Technologies
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2011
Completion date
November 30, 2015
Enrollment
97 (actual)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

critical limb ischemia